{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T12:15:15Z","timestamp":1698408915560},"reference-count":28,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2023.12222","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:04:56Z","timestamp":1695618296000},"source":"Crossref","is-referenced-by-count":0,"title":["Myasthenia gravis as initial presentation of a pancreatic neuroendocrine tumor: A case report"],"prefix":"10.3892","volume":"26","author":[{"given":"Elena","family":"Stingu","sequence":"first","affiliation":[{"name":"Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome-Maurice","family":"Dobrowolski","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Bombach","sequence":"additional","affiliation":[{"name":"Department of Neurology and Interdisciplinary Neuro\u2011Oncology, University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Nann","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Singer","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Horger","sequence":"additional","affiliation":[{"name":"Department of Radiology, University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Lauer","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Zender","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Hinterleitner","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Hinterleitner","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, D\u201172076 Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"key20231026123214_b1-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000457956","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Pathology: Diagnosis and prognostic stratification","volume":"105","author":"Perren","year":"2017","journal-title":"Neuroendocrinology"},{"key":"key20231026123214_b2-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4341","article-title":"Biology and evolution of poorly differentiated neuroendocrine tumors","volume":"23","author":"Rickman","year":"2017","journal-title":"Nat Med"},{"key":"key20231026123214_b3-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3322\/caac.21493","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"68","author":"Cives","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"681013","key":"key20231026123214_b4-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.681013","article-title":"A direct comparison of patients with hereditary and sporadic pancreatic neuroendocrine tumors: Evaluation of clinical course, prognostic factors and genotype-phenotype correlations","volume":"12","author":"Soczomski","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20231026123214_b5-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/PAP.0000000000000201","article-title":"Neoplasms of the neuroendocrine pancreas: An update in the classification, definition, and molecular genetic advances","volume":"26","author":"Guilmette","year":"2019","journal-title":"Adv Anat Pathol"},{"issue":"2628","key":"key20231026123214_b6-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112628","article-title":"Updates on Diagnostic and therapeutic management of gastrointestinal and pancreatic NET","volume":"14","author":"Krug","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5669","key":"key20231026123214_b7-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225669","article-title":"Clinical outcomes of everolimus rechallenge in patients with pancreatic neuroendocrine neoplasms with no other treatment options","volume":"14","author":"Kurita","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1267","key":"key20231026123214_b8-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061267","article-title":"Indications of peptide receptor radionuclide therapy (PRRT) in gastroenteropancreatic and pulmonary neuroendocrine tumors: An updated review","volume":"10","author":"Camus","year":"2021","journal-title":"J Clin Med"},{"key":"key20231026123214_b9-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/MPA.0000000000001852","article-title":"Use of chromogranin a for monitoring patients with pancreatic neuroendocrine neoplasms","volume":"50","author":"Yu","year":"2021","journal-title":"Pancreas"},{"issue":"e210647","key":"key20231026123214_b10-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0647","article-title":"Serum levels of neuron-specific enolase as a prognostic factor for disease progression in patients with GET\/NEN in the pancreas and the small intestine","volume":"11","author":"Fuksiewicz","year":"2022","journal-title":"Endocr Connect"},{"issue":"671","key":"key20231026123214_b11-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070671","article-title":"Myasthenia gravis: Pathogenic effects of autoantibodies on neuromuscular architecture","volume":"8","author":"Koneczny","year":"2019","journal-title":"Cells"},{"issue":"596981","key":"key20231026123214_b12-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.596981","article-title":"Myasthenia gravis: Autoantibody specificities and their role in MG management","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front Neurol"},{"issue":"212","key":"key20231026123214_b13-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody specificities in myasthenia gravis; Implications for improved diagnostics and therapeutics","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front Immunol"},{"key":"key20231026123214_b14-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/mus.25973","article-title":"B cells in the pathophysiology of myasthenia gravis","volume":"57","author":"Yi","year":"2018","journal-title":"Muscle Nerve"},{"key":"key20231026123214_b15-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/cmi.2010.74","article-title":"Thymoma and autoimmunity","volume":"8","author":"Shelly","year":"2011","journal-title":"Cell Mol Immunol"},{"issue":"e14719","key":"key20231026123214_b16-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14719","article-title":"Association between myasthenia gravis and systemic lupus erythematosus as a comorbid state","volume":"13","author":"Ali","year":"2021","journal-title":"Cureus"},{"key":"key20231026123214_b17-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3889\/oamjms.2018.110","article-title":"Myasthenia gravis and associated diseases","volume":"6","author":"Tanovska","year":"2018","journal-title":"Open Access Maced J Med Sci"},{"key":"key20231026123214_b18-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/ene.14730","article-title":"Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study","volume":"28","author":"Verwijst","year":"2021","journal-title":"Eur J Neurol"},{"issue":"140013","key":"key20231026123214_b19-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-14-0013","article-title":"Two patients with a neuroendocrine tumour of the small intestine and paraneoplastic myasthenia gravis","volume":"2014","author":"Hermans","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"S235","key":"key20231026123214_b20-ETM-26-5-12222","article-title":"Myasthenia gravis with coexisting primary pancreatic neuroendocrine tumor in a young female patient","volume":"106","author":"Gay","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"421","key":"key20231026123214_b21-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-013-0421-9","article-title":"Ocular myasthenia gravis: Controversies and updates","volume":"14","author":"Wong","year":"2014","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1597","key":"key20231026123214_b22-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061597","article-title":"Current treatment of myasthenia gravis","volume":"11","author":"Alhaidar","year":"2022","journal-title":"J Clin Med"},{"issue":"604","key":"key20231026123214_b23-ETM-26-5-12222","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.00604","article-title":"A practical approach to managing patients with myasthenia gravis-opinions and a review of the literature","volume":"11","author":"Farrugia","year":"2020","journal-title":"Front Neurol"},{"key":"key20231026123214_b24-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3988\/jcn.2012.8.3.235","article-title":"A patient with coexisting myasthenia gravis and lambert-eaton myasthenic syndrome","volume":"8","author":"Kim","year":"2012","journal-title":"J Clin Neurol"},{"key":"key20231026123214_b25-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/mus.24921","article-title":"Myasthenia gravis Lambert-Eaton overlap syndrome","volume":"53","author":"Oh","year":"2016","journal-title":"Muscle Nerve"},{"key":"key20231026123214_b26-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"key20231026123214_b27-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/j.1468-1331.2008.02242.x","article-title":"Paraneoplastic myasthenia gravis: Immunological and clinical aspects","volume":"15","author":"Skeie","year":"2008","journal-title":"Eur J Neurol"},{"key":"key20231026123214_b28-ETM-26-5-12222","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T09:32:21Z","timestamp":1698312741000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2023.12222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,9,25]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2023.12222","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"article-number":"523"}}